Document is current

Article History

Received: 9 June 2024

Accepted: 7 August 2024

First Online: 13 September 2024

Declarations

:

: The RECOVAC studies were approved by the Ethics Board of the University Medical Center Groningen (No 2020/662, 2021/099 and 2021/507). For the present study no ethical clearance was requested as it concerned a process evaluation of a research project that already received ethical clearance, was non-interventional by design and did not contain any patient data. Participants were fully informed and aware of the content of the study and had the opportunity to ask questions and stop their participation at any point in time.

: Not applicable.

: Funding Acquisition: RTG, JSFS. Conceptualization: JPMV, WSK, RTG, ALM, JSFS, RdWL. Methodology: JPMV, WSK, RdWL. Data curation and investigation: JPMV, WSK, RdWL. Formal Analysis: JPMV, WSK, RdWL. Writing and editing: JPMV, WSK, DEMCJ, CB, JdZ, MMHP, RTG, ALM, JSFS, RdWL. Validation: JPMV, WSK, RTG, ALM, JSFS, RdWL. All authors read and approved the final manuscript.

: The authors declare no competing interests.

: The author team consists of authors with a mix of different backgrounds. The main author (JPMV) is a patient representative with an extensive background in patient engagement in research. She is also a PhD student at the Global Health Unit of the department of Health Sciences at the University Medical Center Groningen. This article will be part of her PhD thesis. WSK, MMHP and RdWL are involved on behalf of the Dutch Kidney Patients Association (NVN) and RTG, ALM and JSFS are clinicians and researchers and involved on behalf of the RECOVAC consortium. DEMCJ, CB and JdZ are the supervisory team of the PhD trajectory of JPMV.